371 related articles for article (PubMed ID: 32891692)
21. Impact of dietary fiber supplementation on modulating microbiota-host-metabolic axes in obesity.
Mayengbam S; Lambert JE; Parnell JA; Tunnicliffe JM; Nicolucci AC; Han J; Sturzenegger T; Shearer J; Mickiewicz B; Vogel HJ; Madsen KL; Reimer RA
J Nutr Biochem; 2019 Feb; 64():228-236. PubMed ID: 30572270
[TBL] [Abstract][Full Text] [Related]
22. The pathophysiology of bile acid diarrhoea: differences in the colonic microbiome, metabolome and bile acids.
Sagar NM; Duboc H; Kay GL; Alam MT; Wicaksono AN; Covington JA; Quince C; Kokkorou M; Svolos V; Palmieri LJ; Gerasimidis K; Walters JRF; Arasaradnam RP
Sci Rep; 2020 Nov; 10(1):20436. PubMed ID: 33235223
[TBL] [Abstract][Full Text] [Related]
23. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids.
Yao Y; Yan L; Chen H; Wu N; Wang W; Wang D
Phytomedicine; 2020 Oct; 77():153268. PubMed ID: 32663709
[TBL] [Abstract][Full Text] [Related]
24. Microbiome-Metabolomics Analysis of the Impacts of
Wang L; Cao L; Chang Y; Fu Y; Wang Y; Zhang K; Zhang S; Zhang L
Microbiol Spectr; 2023 Feb; 11(1):e0217522. PubMed ID: 36533947
[TBL] [Abstract][Full Text] [Related]
25. Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes.
Mandaliya DK; Seshadri S
Pancreatology; 2019 Mar; 19(2):280-284. PubMed ID: 30713129
[TBL] [Abstract][Full Text] [Related]
26. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.
Hosseinkhani F; Heinken A; Thiele I; Lindenburg PW; Harms AC; Hankemeier T
Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33590776
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory bowel disease is associated with increased gut-to-blood penetration of short-chain fatty acids: A new, non-invasive marker of a functional intestinal lesion.
Jaworska K; Konop M; Bielinska K; Hutsch T; Dziekiewicz M; Banaszkiewicz A; Ufnal M
Exp Physiol; 2019 Aug; 104(8):1226-1236. PubMed ID: 31243807
[TBL] [Abstract][Full Text] [Related]
28. Sex, Food, and the Gut Microbiota: Disparate Response to Caloric Restriction Diet with Fiber Supplementation in Women and Men.
Benítez-Páez A; Hess AL; Krautbauer S; Liebisch G; Christensen L; Hjorth MF; Larsen TM; Sanz Y;
Mol Nutr Food Res; 2021 Apr; 65(8):e2000996. PubMed ID: 33629506
[TBL] [Abstract][Full Text] [Related]
29. Chitosan oligosaccharides attenuate loperamide-induced constipation through regulation of gut microbiota in mice.
Zhang X; Yang H; Zheng J; Jiang N; Sun G; Bao X; Lin A; Liu H
Carbohydr Polym; 2021 Feb; 253():117218. PubMed ID: 33278982
[TBL] [Abstract][Full Text] [Related]
30. Normal Light-Dark and Short-Light Cycles Regulate Intestinal Inflammation, Circulating Short-chain Fatty Acids and Gut Microbiota in
Zhen Y; Ge L; Xu Q; Hu L; Wei W; Huang J; Loor JJ; Yang Q; Wang M; Zhou P
Front Immunol; 2022; 13():848248. PubMed ID: 35371053
[TBL] [Abstract][Full Text] [Related]
31. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
Peng K; Xia S; Xiao S; Yu Q
J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
[TBL] [Abstract][Full Text] [Related]
32. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
Zhu T; Goodarzi MO
Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
[TBL] [Abstract][Full Text] [Related]
33. Reproducibility, Temporal Variability, and Concordance of Serum and Fecal Bile Acids and Short Chain Fatty Acids in a Population-Based Study.
Farhat Z; Sampson JN; Hildesheim A; Safaeian M; Porras C; Cortés B; Herrero R; Romero B; Vogtmann E; Sinha R; Loftfield E
Cancer Epidemiol Biomarkers Prev; 2021 Oct; 30(10):1875-1883. PubMed ID: 34376486
[TBL] [Abstract][Full Text] [Related]
34. Bile acids supplementation modulates lipid metabolism, intestinal function, and cecal microbiota in geese.
Li G; Wang X; Liu Y; Gong S; Yang Y; Wang C; Wang H; He D
Front Microbiol; 2023; 14():1185218. PubMed ID: 37303790
[TBL] [Abstract][Full Text] [Related]
35. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.
Shin Y; Han S; Kwon J; Ju S; Choi TG; Kang I; Kim SS
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892541
[TBL] [Abstract][Full Text] [Related]
36. Pulsatilla decoction improves DSS-induced colitis via modulation of fecal-bacteria-related short-chain fatty acids and intestinal barrier integrity.
Niu C; Hu XL; Yuan ZW; Xiao Y; Ji P; Wei YM; Hua YL
J Ethnopharmacol; 2023 Jan; 300():115741. PubMed ID: 36162543
[TBL] [Abstract][Full Text] [Related]
37. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease.
Wang Y; Gao X; Zhang X; Xiao F; Hu H; Li X; Dong F; Sun M; Xiao Y; Ge T; Li D; Yu G; Liu Z; Zhang T
Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33430702
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
[TBL] [Abstract][Full Text] [Related]
39. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health.
Nogal A; Valdes AM; Menni C
Gut Microbes; 2021; 13(1):1-24. PubMed ID: 33764858
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic potential of short-chain fatty acid production by gut microbiota in neurodegenerative disorders.
Yadav S; Dwivedi A; Tripathi A; Tripathi AK
Nutr Res; 2022 Oct; 106():72-84. PubMed ID: 36152586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
